RBBP4 and pancreatic neoplasm: Consistent with these results, we confirmed that miR-6794-3p-mediated inhibition of RBBP4 increases GRHL2 expression, in turn, suppressing pancreatic cancer cell invasion and migration (Figure 6E-H).